Eloxx Pharmaceuticals Inc.
ELOX | NASDAQ
$13.45
+$0.27 (+2.05%)
At close: Oct 30, 2026, 4:00 PM ET
$13.20
-$0.25 (-1.86%)
Pre-market:
Nov 2, 2026, 8:54 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q1 2025 Mar 31, 2025 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -9.13 | -12.80 | -2.22 | -0.11 | -0.09 | -0.07 | 0 | -0.05 | -0.05 | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 |
PEG Ratio | 0.39 | n/a | n/a | 0 | 0 | 0.05 | 0 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.03 | -6.36 | n/a | -0.14 | -0.12 | -0.13 | -0.20 | -0.44 | 1.20 | 0.19 | 0.10 | 0.07 | 0.04 | 0.37 |
P/FCF Ratio | -9.20 | -8.85 | 3.16 | -0.22 | -0.14 | -0.09 | n/a | -0.06 | -0.06 | -0.06 | -0.06 | -0.07 | -0.06 | -0.04 |
P/OCF Ratio | -9.20 | -8.85 | 3.16 | -0.22 | -0.14 | -0.09 | n/a | -0.06 | -0.06 | -0.06 | -0.06 | -0.07 | -0.06 | -0.04 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | -0.29 | -0.33 | -0.38 | -1.26 | -2.69 | 7.42 | 1.15 | 0.60 | 0.41 | 0.28 | 3.91 |
Quick Ratio | 3.74 | 0.48 | n/a | 0.24 | 0.25 | 0.33 | 0.87 | 1.18 | 1.62 | 2.20 | 4.37 | 5.61 | 3.85 | 1.57 |
Current Ratio | 3.74 | 0.48 | n/a | 0.24 | 0.25 | 0.33 | 0.87 | 1.18 | 1.62 | 2.20 | 4.37 | 5.61 | 3.85 | 1.57 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -556.25 | -130.86 | -2.53 | -15.48 | -18 | -11.31 | -10.38 | -14.61 | -21.68 | -27.11 | -25.50 | -45.74 | -40.94 | -32.36 |
Return on Equity | -9.70% | 49.50% | n/a | 17.92% | 23.34% | 38.24% | 59.28% | 150.70% | -585.98% | -99.44% | -54.01% | -29.96% | -88.72% | -316.15% |
Return on Assets | -7.10% | -44.15% | n/a | -59.45% | -72.43% | -86.53% | -29.92% | -27.93% | -32.23% | -26.64% | -26.78% | -17.85% | -59.49% | -42.69% |
Return on Invested Capital | -9.59% | 50.04% | n/a | 25.45% | 33.15% | 54.52% | -218.63% | -84.75% | -67.52% | -43.65% | -32.45% | -22.01% | -25.19% | -62.26% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ELOX